187 related articles for article (PubMed ID: 28889388)
21. Urinary mRNA biomarker panel for the detection of urothelial carcinoma.
Urquidi V; Netherton M; Gomes-Giacoia E; Serie D; Eckel-Passow J; Rosser CJ; Goodison S
Oncotarget; 2016 Jun; 7(25):38731-38740. PubMed ID: 27231851
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA expression profiling in bladder cancer: the challenge of next-generation sequencing in tissues and biofluids.
Matullo G; Naccarati A; Pardini B
Int J Cancer; 2016 May; 138(10):2334-45. PubMed ID: 26489968
[TBL] [Abstract][Full Text] [Related]
23. A modified precipitation method to isolate urinary exosomes.
Kanchi Ravi R; Khosroheidari M; DiStefano JK
J Vis Exp; 2015 Jan; (95):51158. PubMed ID: 25651044
[TBL] [Abstract][Full Text] [Related]
24. The role of microRNAs in bladder cancer.
Enokida H; Yoshino H; Matsushita R; Nakagawa M
Investig Clin Urol; 2016 Jun; 57 Suppl 1(Suppl 1):S60-76. PubMed ID: 27326409
[TBL] [Abstract][Full Text] [Related]
25. Urinary cell-free microRNA-106b as a novel biomarker for detection of bladder cancer.
Zhou X; Zhang X; Yang Y; Li Z; Du L; Dong Z; Qu A; Jiang X; Li P; Wang C
Med Oncol; 2014 Oct; 31(10):197. PubMed ID: 25168920
[TBL] [Abstract][Full Text] [Related]
26. Quantitative Analysis of Exosomal miRNA via qPCR and Digital PCR.
Bellingham SA; Shambrook M; Hill AF
Methods Mol Biol; 2017; 1545():55-70. PubMed ID: 27943207
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of Cell-Free Urine microRNAs Expression for the Use in Diagnosis of Ovarian and Endometrial Cancers. A Pilot Study.
Záveský L; Jandáková E; Turyna R; Langmeierová L; Weinberger V; Záveská Drábková L; Hůlková M; Hořínek A; Dušková D; Feyereisl J; Minář L; Kohoutová M
Pathol Oncol Res; 2015 Sep; 21(4):1027-35. PubMed ID: 25827090
[TBL] [Abstract][Full Text] [Related]
28. MicroRNAs: Key Players in Bladder Cancer.
Li Q; Wang H; Peng H; Huang Q; Huyan T; Huang Q; Yang H; Shi J
Mol Diagn Ther; 2019 Oct; 23(5):579-601. PubMed ID: 31325035
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic Potential of Circulating Tumor Cells, Urinary MicroRNA, and Urinary Cell-Free DNA for Bladder Cancer: A Review.
Koguchi D; Matsumoto K; Shiba I; Harano T; Okuda S; Mori K; Hirano S; Kitajima K; Ikeda M; Iwamura M
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012417
[TBL] [Abstract][Full Text] [Related]
30. Variability in microRNA recovery from plasma: Comparison of five commercial kits.
Brunet-Vega A; Pericay C; Quílez ME; Ramírez-Lázaro MJ; Calvet X; Lario S
Anal Biochem; 2015 Nov; 488():28-35. PubMed ID: 26271186
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic and prognostic value of bladder cancer-related transcript markers in urine.
Schmidt J; Propping C; Siow WY; Lohse-Fischer A; Toma M; Baldauf-Twelker A; Hakenberg OW; Wirth MP; Fuessel S
J Cancer Res Clin Oncol; 2016 Feb; 142(2):401-14. PubMed ID: 26328914
[TBL] [Abstract][Full Text] [Related]
32. Comparison of MicroRNA Content in Plasma and Urine Indicates the Existence of a Transrenal Passage of Selected MicroRNAs.
Pazourkova E; Pospisilova S; Svobodova I; Horinek A; Brisuda A; Soukup V; Hrbacek J; Capoun O; Mares J; Hanus T; Babjuk M; Korabecna M
Adv Exp Med Biol; 2016; 924():97-100. PubMed ID: 27753026
[TBL] [Abstract][Full Text] [Related]
33. Quantitative analysis of survivin mRNA expression in urine and tumor tissue of bladder cancer patients and its potential relevance for disease detection and prognosis.
Weikert S; Christoph F; Schrader M; Krause H; Miller K; Müller M
Int J Cancer; 2005 Aug; 116(1):100-4. PubMed ID: 15761870
[TBL] [Abstract][Full Text] [Related]
34. Role of Exosomal miRNA in Bladder Cancer: A Promising Liquid Biopsy Biomarker.
Piao XM; Cha EJ; Yun SJ; Kim WJ
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33567779
[TBL] [Abstract][Full Text] [Related]
35. Cell-free urinary microRNA-99a and microRNA-125b are diagnostic markers for the non-invasive screening of bladder cancer.
Zhang DZ; Lau KM; Chan ES; Wang G; Szeto CC; Wong K; Choy RK; Ng CF
PLoS One; 2014; 9(7):e100793. PubMed ID: 25014919
[TBL] [Abstract][Full Text] [Related]
36. A two-gene methylation signature for the diagnosis of bladder cancer in urine.
Bosschieter J; Nieuwenhuijzen JA; Hentschel A; van Splunter AP; Segerink LI; Vis AN; Wilting SM; Lissenberg-Witte BI; A van Moorselaar RJ; Steenbergen RD
Epigenomics; 2019 Feb; 11(3):337-347. PubMed ID: 30706728
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of optimal extracellular vesicle small RNA isolation and qRT-PCR normalisation for serum and urine.
Crossland RE; Norden J; Bibby LA; Davis J; Dickinson AM
J Immunol Methods; 2016 Feb; 429():39-49. PubMed ID: 26723490
[TBL] [Abstract][Full Text] [Related]
38. Integrative functional genetic-epigenetic approach for selecting genes as urine biomarkers for bladder cancer diagnosis.
Eissa S; Matboli M; Essawy NO; Kotb YM
Tumour Biol; 2015 Dec; 36(12):9545-52. PubMed ID: 26138586
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-218 inhibits bladder cancer cell proliferation, migration, and invasion by targeting BMI-1.
Cheng Y; Yang X; Deng X; Zhang X; Li P; Tao J; Lu Q
Tumour Biol; 2015 Sep; 36(10):8015-23. PubMed ID: 25967457
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of urinary miRNA-96 as a potential biomarker for bladder cancer diagnosis.
Eissa S; Habib H; Ali E; Kotb Y
Med Oncol; 2015 Jan; 32(1):413. PubMed ID: 25511320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
